The results showed that VEGF siRNA loaded in asialoglycoprotein receptor-targeted nanoparticles silenced VEGF both in vitro and in vivo, demonstrated potent anti-angiogenic activity in HCA-1 tumors and suppressed primary HCC growth and distal metastasis [79]. This evidence concerns the gene VEGFA and hepatocellular carcinoma.